After purchase, your eBook will be available on your "My Downloads" page, accessed from your Member/Guest page under "Admin: My Account".
Target Audience: This CME activity has been developed for MDs specializing in psychiatry. There are no prerequisites for this activity. Physicians in all specialties who are interested in psychopharmacology, as well as nurses, psychologists, and pharmacists, are welcome for advanced study.
Overview: The successful treatment of major depressive disorder depends largely on a proper diagnosis, an adequate choice of medication, and adherence to pharmacotherapy. This booklet explains the mechanisms of action of antidepressants, illustrates how to treat women across their life cycle, and discusses various comorbidities of major depressive disorder.
Learning Objectives: After completing this activity, participants should be better able to fulfill the following learning objectives:
Accreditation and Credit Designation Statements: The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- Identify neural implications of depression and describe neurobiologic symptoms
- Utilize treatment options available for depression on a per-case basis
- Discuss comorbidities associated with depression
The Neuroscience Education Institute designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Also available will be a certificate of participation for completing this activity.
Nurses in most states may claim full credit for activities approved for AMA PRA Category 1 Credits™ (for up to half of their recertification credit requirements). This activity is designated for 3.0 AMA PRA Category 1 Credits™.
Release Date: August 15, 2009
CME Credit Expiration Date: August 14, 2012
Media: Printed monograph
Sponsor: This activity is sponsored by Neuroscience Education Institute.
Support: This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; and Lilly USA, LLC. For further information concerning Lilly grant funding visit, www.lillygrantoffice.com.